PRELUDE THERAPEUTICS INC

PRLD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Nov 4, 2025
4 Oct 20, 2025 PRIMARY DOCUMENT
3 Oct 20, 2025
8-K Oct 17, 2025 8-K
4 Oct 7, 2025 PRIMARY DOCUMENT
8-K Sep 19, 2025 8-K
10-Q Aug 14, 2025 10-Q
8-K Aug 14, 2025 8-K
4 Jul 8, 2025 PRIMARY DOCUMENT
SCHEDULE 13D/A Jun 13, 2025
4 Jun 13, 2025 4
3 Jun 13, 2025 3
4 Jun 13, 2025 PRIMARY DOCUMENT
4 Jun 13, 2025 PRIMARY DOCUMENT
4 Jun 13, 2025 PRIMARY DOCUMENT
4 Jun 13, 2025 PRIMARY DOCUMENT
4 Jun 13, 2025 PRIMARY DOCUMENT
8-K Jun 13, 2025 8-K
SCHEDULE 13G/A May 15, 2025
10-Q May 6, 2025 10-Q
8-K May 6, 2025 8-K
ARS Apr 29, 2025 ARS
DEFA14A Apr 29, 2025 DEFA14A
DEF 14A Apr 29, 2025 DEF 14A
8-K Apr 25, 2025 8-K
← Newer Page 3 of 16 · 389 filings Older →